Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of a Single Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

NCT04368429 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04368429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04368429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of a Single Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
May 22, 2020
Completion date
November 7, 2020
Enrollment
360 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal immunisation (healthy volunteers)